AADC polynucleotides for the treatment of parkinson's disease
US10335466B2 · kind B2 · utility
9Cited by
248References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 5, 2015 |
| Grant date | Jul 2, 2019 |
| Priority date | — |
| Expiry date | Feb 17, 2036 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2830/50
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to compositions and methods for the preparation, manufacture and therapeutic use of polynucleotides encoding AADC for the treatment of Parkinson's Disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.